Intraoperative fibrin formation during Descemet membrane endothelial keratoplasty

[1]  Z. M. Mayko,et al.  Relationship Between Tissue Unscrolling Time and Endothelial Cell Loss , 2016, Cornea.

[2]  D. Ponzin,et al.  Contact Lens-Assisted Pull-Through Technique for Delivery of Tri-Folded (Endothelium in) DMEK Grafts Minimizes Surgical Time and Cell Loss. , 2016, Ophthalmology.

[3]  Z. M. Mayko,et al.  The First 100 Eyes of Standardized Descemet Stripping Automated Endothelial Keratoplasty versus Standardized Descemet Membrane Endothelial Keratoplasty. , 2015, Ophthalmology.

[4]  Christopher G. Stoeger,et al.  Stamping an S on DMEK Donor Tissue to Prevent Upside-Down Grafts: Laboratory Validation and Detailed Preparation Technique Description , 2015, Cornea.

[5]  Z. M. Mayko,et al.  Standardized DMEK Technique: Reducing Complications Using Prestripped Tissue, Novel Glass Injector, and Sulfur Hexafluoride (SF6) Gas , 2015, Cornea.

[6]  Marcus Ang,et al.  Descemet Membrane Endothelial Keratoplasty: Intraoperative and Postoperative Imaging Spectral-Domain Optical Coherence Tomography , 2015, Case reports in ophthalmological medicine.

[7]  A. Dubey,et al.  Intraoperative and Immediate Postoperative Outcomes of Cataract Surgery using Phacoemulsification in Eyes with and without Pseudoexfoliation Syndrome. , 2014, Journal of clinical and diagnostic research : JCDR.

[8]  R. Zarei,et al.  Inhibition of intraocular fibrin formation after infusion of low‐molecular‐weight heparin during combined phacoemulsification–trabeculectomy surgery , 2006, Journal of cataract and refractive surgery.

[9]  U. Rehany,et al.  Intraoperative enoxaparin minimizes inflammatory reaction after pediatric cataract surgery. , 2006, American journal of ophthalmology.

[10]  K. Boboridis,et al.  Low‐dose tissue plasminogen activator in the management of anterior chamber fibrin formation , 2003, Journal of cataract and refractive surgery.

[11]  S. Khokhar,et al.  Phacoemulsification in filtered chronic angle closure glaucoma eyes , 2002, Clinical & experimental ophthalmology.

[12]  T. Starck.  Treatment of Fibrinous Effusion , 1998, Journal of cataract and refractive surgery.

[13]  I. Polzer,et al.  Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery , 1997, Journal of cataract and refractive surgery.

[14]  R. Yee,et al.  Low‐dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes , 1995, Journal of cataract and refractive surgery.